Yumi Otoyama

Hatanodai, 1428555, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma.

ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma.

Journal: Clinical pharmacokinetics

Published: January 05, 2026

Combined Assessment Findings of High Spleen Index and Fibrosis-4 Index Correlate With Fibrosis Progression in Fontan-Associated Liver Disease: A Retrospective Study.

Combined Assessment Findings of High Spleen Index and Fibrosis-4 Index Correlate With Fibrosis Progression in Fontan-Associated Liver Disease: A Retrospective Study.

Journal: Cureus

Published: November 27, 2025

Complete Response After One Cycle of Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma: Two High-Risk Contexts, Child-Pugh Class B and Advanced Age.

Complete Response After One Cycle of Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma: Two High-Risk Contexts, Child-Pugh Class B and Advanced Age.

Journal: Cureus

Published: November 24, 2025

Vedolizumab Induces Remission in Two Cases of Ulcerative Colitis With Upper Gastrointestinal Involvement.

Vedolizumab Induces Remission in Two Cases of Ulcerative Colitis With Upper Gastrointestinal Involvement.

Journal: DEN open

Published: May 31, 2025

Kampo medicine inducing drug-induced liver injury: A case report and systematic review.

Kampo medicine inducing drug-induced liver injury: A case report and systematic review.

Journal: Drug discoveries & therapeutics

Published: January 05, 2025

A case of Budd-Chiari syndrome with acute venous thrombosis and liver failure: highlighting the importance of early intervention and anticoagulation therapy.

A case of Budd-Chiari syndrome with acute venous thrombosis and liver failure: highlighting the importance of early intervention and anticoagulation therapy.

Journal: Clinical journal of gastroenterology

Published: December 06, 2024

Cholangitis and Congestive Heart Failure Secondary to Biliary Hemorrhage in Hereditary Hemorrhagic Telangiectasia.

Cholangitis and Congestive Heart Failure Secondary to Biliary Hemorrhage in Hereditary Hemorrhagic Telangiectasia.

Journal: Cureus

Published: December 06, 2024

The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review.

The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review.

Journal: Oncogene

Published: October 29, 2022

A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review.

A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review.

Journal: OncoTargets and therapy

Published: July 26, 2022

Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer.

Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer.

Journal: BMC cancer

Published: December 25, 2021

Muscular Metastasis of Hepatocellular Carcinoma: Case Report and Literature Review.

Muscular Metastasis of Hepatocellular Carcinoma: Case Report and Literature Review.

Journal: Internal medicine (Tokyo, Japan)

Published: July 05, 2021

Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10.

Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10.

Journal: Anticancer research

Published: March 25, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026